13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0000909661
Total reported value
$21.7B
$21.7B
4 檔
5.6%
At the close of Q1 2024, Farallon Capital Management, L.l.c. disclosed equity holdings valued at approximately $21.7B, spread across 4 reported holdings.
In Q1 2024, Farallon Capital Management, L.l.c. displayed an active expansion posture, initiating 8 new positions and adding to 20 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | HES | Hess CORP | Stock-Other | 80.38% | — | +116.13% | |
| 2 | USX1 | United States Steel CORP | Stock-Other | 10.65% | — | +30.23% | |
| 3 | AKX | Ansys Inc | Stock-Other | 7.25% | — | — | |
| 4 | DFSEUR | Discover Financial Services | Stock-Other | 1.72% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | PXDEUR | Pioneer Natural Resources Co | +4.2% | NEW | New buy |
| 2 | IBB | Ishares Biotechnology ETF | +2.2% | NEW | New buy |
| 3 | ABNB | Airbnb Inc-class A | +1.2% | NEW | New buy |
| 4 | AON | Aon plc | +1% | NEW | New buy |
| 5 | SRPT | Sarepta Therapeutics Inc | +0.9% | — | Add |
| 6 | UNH | Unitedhealth Group Inc | +0.7% | — | Add |
| 7 | NTRA | Natera Inc | +0.6% | — | Add |
| 8 | NDAQ | Nasdaq Inc | +0.5% | — | Add |
| 9 | GBTC | Grayscale Bitcoin Trust ETF | +0.4% | NEW | New buy |
| 10 | LNTH | Lantheus Holdings Inc | +0.4% | — | Add |
| 11 | AGIO | Agios Pharmaceuticals Inc | +0.3% | — | Add |
| 12 | ARMK | Aramark | +0.3% | — | Add |
| 13 | ICLR | ICON Public Limited Company | +0.3% | NEW | New buy |
| 14 | ✓ | Longboard Pharmaceuticals In | +0.2% | — | Add |
| 15 | EDU | New Oriental Educatio-sp Adr | +0.2% | — | Add |
| 16 | MASI* | Masimo CORP | +0.2% | — | Add |
| 17 | SIMO | Silicon Motion Technol-adr | +0.2% | — | Add |
| 18 | XBI | Ss Spdr S&p Biotech ETF | +0.2% | NEW | New buy |
| 19 | COR | Cencora Inc | +0.2% | — | Add |
| 20 | THC | Tenet Healthcare CORP | +0.2% | — | Add |
| 21 | CRM | Salesforce Inc | +0.2% | — | Add |
| 22 | RVMD | Revolution Medicines Inc | +0.1% | — | Add |
| 23 | LQDA | Liquidia CORP | +0.1% | NEW | New buy |
| 24 | BEAM | Beam Therapeutics Inc | +0.1% | — | Add |
| 25 | PCVX | Vaxcyte Inc | +0.1% | — | Add |
| 26 | HIMS | Hims & Hers Health Inc | +0.1% | — | Add |
| 27 | GOOG | Alphabet Inc-cl C | +0.1% | — | Add |
| 28 | PTGX | Protagonist Therapeutics Inc | +0.1% | — | Add |
| 29 | IQV | Iqvia Holdings Inc | -0.2% | — | Trim |
| 30 | HUM | Humana Inc | -0.2% | — | Trim |
| 31 | EVH | Evolent Health Inc - A | -0.2% | — | Trim |
| 32 | PACB | Pacific Biosciences Of Calif | -0.2% | — | Trim |
| 33 | IONS | Ionis Pharmaceuticals Inc | -0.3% | — | Trim |
| 34 | INSP | Inspire Medical Systems Inc | -0.3% | — | Trim |
| 35 | CTLTEUR | Catalent Inc | -0.3% | EXIT | Sold out |
| 36 | ROIV | Roivant Sciences Ltd. | -0.4% | — | Trim |
| 37 | SPGI | S&p Global Inc | -0.4% | — | Trim |
| 38 | UTHR | United Therapeutics CORP | -0.4% | — | Trim |
| 39 | CYTK | Cytokinetics Inc | -0.4% | — | Trim |
| 40 | VNET 0 02-01-26Bond | Vnet Group Inc | -0.4% | EXIT | Sold out |
| 41 | YMM | Full Truck Alliance -spn Adr | -0.5% | — | Trim |
| 42 | WAB | Wabtec CORP | -0.5% | — | Trim |
| 43 | MRTXEUR | Mirati Therapeutics Inc | -0.6% | EXIT | Sold out |
| 44 | CNC | Centene CORP | -0.6% | — | Trim |
| 45 | TRU | Transunion | -0.8% | — | Trim |
| 46 | AZNN | Astrazeneca Plc-spons Adr | -0.8% | — | Trim |
| 47 | TMO | Thermo Fisher Scientific Inc | -1.1% | — | Trim |
| 48 | BX | Blackstone Inc | -1.1% | EXIT | Sold out |
| 49 | CHTR | Charter Communications Inc-a | -1.5% | EXIT | Sold out |
| 50 | SPY | Ss Spdr S&p 500 ETF Trust-us | -1.8% | — | Trim |
According to official SEC Form 13F filings, Farallon Capital Management, L.l.c. reported a total U.S. public equity portfolio value of $21.7B across 4 disclosed positions in Q1 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including HES, USX1, AKX) accounted for 5.6% of total reported equity market value during Q1 2024.
Top New Position Initiated
PXDEUR
市值: $924.0M
Top Position Liquidated / Trimmed
CHTR
前期市值: $310.6M
During Q1 2024, Farallon Capital Management, L.l.c.'s top holdings by market value included HES (80.4%)、USX1 (10.7%)、AKX (7.3%). The largest single position, HES, represented 80.4% of total portfolio value.
In Q1 2024, Farallon Capital Management, L.l.c. made 50 total portfolio adjustments, initiating 8 new buys, adding to 20 positions, trimming 17 holdings, and fully liquidating 5 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.